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Abstract Four individual LG modules from the C-terminus of
the laminin K2 chain (LG1, LG2, LG4 and LG5) and
combinations of these modules were prepared as recombinant
products from transfected mammalian cells. This demonstrated
that LG modules represent autonomously folding protein
domains. Successful production depended on proper alignment
of module borders and required a sequence correction at the C-
terminus which added an extra cysteine. The LG modules were
glycosylated and shown by electron microscopy to have a
globular shape, indicating proper folding. Evidence is provided
for the splicing of a 12 bp exon in LG2, although this did not
impair folding. Proteolytic cleavage at the C-terminus of a basic
sequence was observed close to the N-terminus of LG3. A similar
processing also occurs in tissue-derived laminin-2 and -4 which
contain the K2 chain.
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1. Introduction
Laminins are major basement membrane proteins for which
at least 11 isoforms exist. This diversity is mainly due to ¢ve
di¡erent K chains (K1^K5) of 200^400 kDa which combine
with smaller numbers of L and Q chains into disul¢de-bonded
heterotrimers [1]. A common hallmark of the laminin K chain
structure is the presence of ¢ve laminin-type G domain (LG)
modules arranged at the C-terminus in a tandem array. LG
modules consist of 180^200 residues and have been identi¢ed
in various extracellular proteins and receptors, although the
sequence identity is generally low (20^30%). As well as being
found in laminins, they also occur in the basement membrane
proteoglycans perlecan [2] and agrin [3,4] and in less related
proteins such as hormone-binding proteins [5], neurexin re-
ceptors [6] and proteins involved in Drosophila di¡erentiation
[7], indicating that they are involved in important functions.
In laminins, modules LG1^LG5 form a large globular domain
at the distal end of the long arm which appears to consist of
subdomains when visualized by negative staining [8]. It has
not yet been established whether individual LG modules are
autonomously folding units or whether they need to be incor-
porated into larger structures for proper folding.
Potential functions of LG modules have been most exten-
sively studied using laminin-1 (chain composition K1L1Q1).
The laminin-1 LG modules bind to heparin, sulfatides, perle-
can and ¢bulin-1 [9], as well as cellular receptors including
K6L1, K7L1 and some other integrins [10], and K-dystroglycan
[11]. Laminin-2 (K2L1Q1) and laminin-4 (K2L2Q1) are the iso-
forms most similar to laminin-1, and also show a broad tissue
expression [12,13] but only a partially overlapping deposition
at certain anatomical sites [14,15]. These K2 chain-containing
laminins are particularly prominent in skeletal muscle and are
directly or indirectly involved in several inherited or transgen-
ic muscular dystrophies [1,16^18]. Despite such speci¢c fea-
tures, laminin-2 and laminin-4 are similar to laminin-1 in that
they self-assemble into networks [19], mediate cell adhesion
via L1 integrins, have a moderate a⁄nity for heparin [20]
and promote neurite outgrowth [21]. It therefore appears
very likely that several of these activities are mediated by
the LG modules of the laminin K2 chain.
Laminin-2 and -4 can be puri¢ed from tissues [20,22] but
because of their large size and low yields they are not appro-
priate for structural and functional mapping studies. Re-
combinant production methods, as shown for the LG modules
of the laminin K1 chain [23], seem to be more suitable. In the
present study we have used established technologies to pre-
pare individual LG modules and some larger fragments of the
mouse laminin K2 chain in mammalian cells in order to ensure
their proper folding and post-translational processing. The
initial aim was to study module borders and folding properties
and to examine proteolytic cleavage as indicated from tissue
studies [20,24], but their successful production has also set the
stage for binding studies.
2. Materials and methods
2.1. Vector construction and recombinant protein production
Mouse laminin K2 chain cDNA clone pmm 16 [13] was used as a
template to amplify the sequence encoding the ¢ve LG modules in-
dividually or in combination (Table 1) by polymerase chain reaction
(PCR) with Vent polymerase (New England Biolabs) following the
manufacturer’s instructions. The 5P end primers used were GTCAGC-
TAGCGGGAGGTGACTGTGTTC (LG1, LG1^3), GTCAGCTA-
GCCAGCCCACAAGTCGAAGAT (LG2), GTCAGCTAGCTGTG-
GAGCTTGCCGCTGT (LG3), GTCAGCTAGCGTCGGTGCCC-
ACCCCTGC (LG4, LG4^5) and GTCAGCTAGCTGCGAATGCA-
GAGAGTGGG (LG5.1, LG5.2). The 3P end primers used were GT-
CACTCGAGCTAGCTGACAGTACATCCCTTAC (LG1), GTCA-
CTCGAGCTACTCCACAAAACCAGGCTTG (LG2), GTCACTC-
GAGCTACGACTGAGGCTGGACAATA (LG3, LG1^3), GTCAC-
TCGAGCTACGCAAAGCATGTCCCAA (LG4), GTCACTCGAG-
TCAGTTCCAGGGCCTTGGC (LG5.1) and GTCACTCGAGT-
TAGGTAGTCGGGCATGATAC (LG5.2, LG4^5). In addition to
the coding sequences, these primers introduced a stop codon and
single NheI and XhoI restriction sites in order to allow in-frame in-
sertion of the cDNA distal to the BM-40 signal peptide sequence [25]
present in the episomal expression vector pCEP-Pu [26]. The PCR
products were initially ligated into plasmid pUC18 (Pharmacia) and
sequences were veri¢ed on an 373A automated sequencer (Applied
Biosystems). Since several sequence di¡erences were found the original
cDNA was also sequenced using the same primers. The PCR products
were cut out by NheI and XhoI digestion and ligated into plasmid
pCEP-Pu.
Human embryonic kidney cells 293 which constitutively express the
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EBNA-1 protein from Epstein-Barr virus (293-EBNA, Invitrogen)
were transfected with the constructs [27] and transfectants were se-
lected with 0.5 Wg/ml puromycin (Sigma) and 250 Wg/ml G418 (Gib-
co). Transfected cells were washed extensively with phosphate-buf-
fered saline and grown in serum-free DMEM/F12 medium (Gibco)
for 2 days after which medium was harvested and replaced by new
serum-free medium for another 2 days.
2.2. Puri¢cation of proteins
Conditioned serum-free medium (1 l) was dialyzed against 50 mM
Tris-HCl, pH 8.6, containing 2 mM EDTA, 0.5 mM phenylmethyl-
sulfonyl £uoride (Serva) and 0.5 mM N-ethylmaleimide (Merck). Re-
combinant proteins were isolated on a DEAE-cellulose column (2U30
cm) equilibrated in the same bu¡er and eluted with a linear NaCl
gradient (0^0.4 M, 500 ml). They were then puri¢ed on a Superose
12 column (HR 16/50, Pharmacia) equilibrated in 0.2 M ammonium
acetate, pH 6.8, lyophilized and dissolved in 0.2 M NH4HCO3. Chro-
matography on heparin-Sepharose in 50 mM Tris-HCl pH 7.4 and
elution with a salt gradient (0^0.5 M NaCl) was used for additional
puri¢cation. Reverse phase chromatography in 0.1% tri£uoroacetic
acid was performed on C4 and C18 columns in order to purify the
LG3 fragment and its CNBr peptides. Laminin-2 and laminin-4 were
obtained from human placenta [20].
2.3. Analytical and miscellaneous methods
Protein and hexosamine concentrations were determined on a Bio-
tronik LC 3000 amino acid analyzer after hydrolyzing samples with 6
M and 3 M HCl, respectively (110‡C, 16 h). Amino acid sequences
were determined by Edman degradation on an Applied Biosystems
model 473 sequencer, following the manufacturer’s instructions. Elec-
trophoresis in SDS-polyacrylamide gradient gels followed established
protocols. Electron microscopy of rotary shadowed protein samples
was performed by a standard procedure [28]. MALDI mass spectra
were obtained with a Bruker Re£ex III time-of-£ight mass spectrom-
eter using 2,5-dihydroxybenzoic acid as matrix as previously described
[29]. Total RNA was isolated as described [30] and fractionated by
agarose gel electrophoresis. The fractionated RNA was transferred to
Hybond N membranes (Amersham) and hybridized to 32P-oligola-
beled cDNA clones encoding LG4^5 or LG1^3 in Church bu¡er at
65‡C. The ¢lters were subsequently washed in 0.02 M sodium phos-
phate solutions containing 5% SDS followed by 1% SDS for 2U1 h at
65‡C before autoradiography. Immunization of rabbits with recombi-
nant proteins (2U0.2 mg in complete Freund’s adjuvant) and ELISA
titration followed established procedures. Immunoblotting was carried
out as described previously [31].
3. Results
The alignment of LG modules to determine module borders
in non-interrupted arrays such as found in laminins meets
with some di⁄culties due to variable module size and only
moderate sequence identities [5,7]. Our choice for the laminin
K2 chain is shown schematically in Fig. 1A and was based on
two short conserved sequences and two cysteines close to the
C-terminus which were rather invariant in all ¢ve laminin K
chains. It also made use of the information that a single cys-
teine close to the N-terminus of the LG4 module is essential
for the proper folding of the same module in the K1 chain (Z.
Andac and R. Timpl, unpublished). The starting points of the
slightly overlapping primers for PCR ampli¢cation (Table 1)
were chosen accordingly. A comprehensive sequence analysis
of the ampli¢ed products as well as of the parental cDNA
clone revealed several di¡erences to the previously published
cDNA sequence of the mouse laminin K2 chain [13]. The most
striking one was a 25 amino acid residue sequence including a
14 residue extension at the C-terminus (Fig. 1B), which added
an extra cysteine and made the sequence more similar to that
of the mouse laminin K1 chain [32]. The correctness of the
novel sequence was demonstrated by recombinant analysis
(see below). The other major change was the deletion of the
sequence SMKA in module LG2 (positions 2476^2479 in the
mouse). This sequence was identi¢ed in both the mouse and
human laminin K2 chain [12,13] and, as discussed later, prob-
ably represents a splice variation. More minor di¡erences in-
clude 17 single amino acid replacements based on single bp
changes, 14 of which made the mouse sequence identical to
the human sequence (see legend to Fig. 1B).
The successful expression of recombinant products was an-
alyzed by electrophoresis of serum-free culture medium ob-
tained from transfected cells. Strong bands of about the ex-
pected size were seen for the individual fragments LG1, LG2
and LG4 and the larger combinations LG1^3 and LG4^5. For
LG5 it was important to use the primer 5.2 corresponding to
the novel C-terminus as a construct with the more upstream
primer 5.1 (Fig. 1B) was ine¡ective in recombinant protein
production. In addition, fragment LG3 could not be obtained
using the chosen borders (Table 1), even though LG3 is ex-
pressed in the larger fragment LG1^3, as discussed later. In
order to exclude ine⁄cient transfection as a cause of low
protein production, we carried out Northern blotting of trans-
fected cells with appropriate probes (Fig. 1C). This showed
similar mRNA levels for LG3 and LG5 transfections, the
latter with primer 5.1, when compared to the level of LG5
mRNA obtained with primer 5.2. This clearly demonstrated
that factors other than mRNA levels contribute to low protein
production.
The recombinant fragments were puri¢ed by a combination
of ion exchange and molecular sieve chromatography, as well
as heparin a⁄nity chromatography where appropriate (frag-
ments LG1^3, LG4^5 and LG5). The yields of puri¢ed prod-
ucts were 0.6^1.8 mg/l and their purity was examined by elec-
trophoresis (Fig. 2). Fragments LG1, LG2, LG5 and LG4^5
showed a single major band which started at the expected N-
terminal sequence as shown by Edman degradation (Table 1).
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Table 1
Sequence borders and structural properties of recombinant LG modules of the mouse laminin K2 chain
Fragmenta Sequence positions Molecular mass (kDa) N-terminal sequenced
calculatedb observedc
LG1 2147^2327 19.9 29 GGDC
LG2 2327^2534 22.7 35 SPQV
LG4 2729^2932 22.2 37, 33 SVPXPA
LG5 2932^3118 20.0 26 ANAE
LG1^3 2147^2729 64.4 84, 60, 26 GGD
LG4^5 2729^3118 42.1 53 SVP
aThe LG3 module (2534^2729) could not be obtained as a recombinant product.
bFrom amino acid sequence.
cFrom electrophoretic mobility.
dAPLA derived from vector has been omitted.
J.F. Talts et al./FEBS Letters 426 (1998) 71^7672
Their molecular masses, as estimated from their electropho-
retic migration, were, however, distinctly higher than those
calculated from the sequence (Table 1) which, apart from
LG5, may in part be attributed to N-glycosylation. Fragment
LG4 was produced as a double band (37 and 33 kDa), both of
which started with the same N-terminus. They could be par-
tially separated from each other and from some aggregated
material by molecular sieve chromatography. Fragment LG1^
3 consistently appeared as a 60 kDa fragment starting with
the expected N-terminal sequence and a 26 kDa fragment with
an apparently blocked N-terminus. An uncleaved variant
(about 84 kDa) was only barely visible. Electron microscopy
of individual LG modules showed uniformly small globular
structures as illustrated for LG2 and LG4 (Fig. 3A,B). As
expected, a somewhat bigger size was observed for fragments
LG4^5 (Fig. 3C) and LG1^3 (Fig. 3D). This indicates close
contacts between adjacent LG modules which cannot be re-
solved after rotary shadowing.
Hexosamine analyses demonstrated negligible galactos-
amine levels for individual LG modules (0.3^1.1 residues)
but 4.3 residues for LG1^3 indicating some O-glycosylation
of the LG3 module. N-Glycosylation was somewhat higher
(2^5 residues in LG1, LG2, LG4 and LG4^5 and 14 residues
in LG1^3). Yet these numbers are low when compared to
potential N-glycosylation sites (Fig. 1A), indicating either
modi¢cation by mannose-rich oligosaccharides or incomplete
substitution.
The existence of two electrophoretic bands in fragment
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Fig. 2. Electrophoretic comparison of puri¢ed recombinant frag-
ments from the G domain of the laminin K2 chain. These fragments
were LG1^3 (lane 1), LG1 (lane 2), LG2 (lane 3), LG4^5 (lane 4),
LG4 (lane 5) and LG5 obtained with primer 5.2 (lane 6). Samples
were reduced and the gel was calibrated with reduced markers, de-
noted in kDa.
Fig. 1. Outline of critical parameters for the e⁄cient recombinant production of LG modules of the mouse laminin K2 chain. A: Schematic
alignment of the LG modules used to de¢ne their borders. The alignment is based on two rather conserved sequences (boxed and numbered on
top) typically represented by FVGGLP (1) and DGXWHX (2). A further box (No. 3) in LG3 indicates a RRKRR sequence involved in pro-
teolytic processing. C denotes positions of cysteines and circles potential N-glycosylation sites. B: Correction of the amino acid sequence at the
C-terminus of the mouse LG5 module. The corrected sequence (MK2c) is caused by insertion of a G between nt positions 9333 and 9334 of
mouse K2 cDNA and is compared with the mouse laminin K1 chain (MK1) and the previous [13] mouse K2 chain sequence (MK2). Lines on
top (5.1, 5.2) denote positions of oligonucleotide primers used in PCR (see Section 2). Numbers refer to N-terminal sequence positions and
ignore the loss of a small exon in LG2 (see text). Further single amino acid changes which were identical to the human K2 chain sequence [12]
were: in LG1, I2204 to W and GF2214/2215 to EY; in LG2, N2523Y; in LG3, I2642M; in LG4, V2773A, G2802A, G2810A, F2820Y,
S2829D and G2878V; and in LG5, G2945A, I2953K and Y3022H. Three more changes (V2739A, R2831S, I2976V) did not correspond to the
human sequence. All these changes were also present in the parental cDNA and have now been deposited to the GenBank (U12147). C: Exam-
ples of Northern blots showing the e⁄ciency of 293-EBNA cell transfections. Lanes were loaded with 10 Wg total RNA after transfection with
LG5 using either primer 5.2 (lane 1) or 5.1 (lane 2) or after transfection with LG3 (lane 3). The size of the mRNA (about 1.2 kb) was as ex-
pected. Only the cells shown in lane 1 showed e⁄cient protein production.
J.F. Talts et al./FEBS Letters 426 (1998) 71^76 73
LG1^3 in about stoichiometric proportions suggested endog-
enous proteolysis, probably close to the N-terminus of the
LG3 module, which contains a unique basic sequence (Fig.
1A). This was of special interest since the K2 chain of tissue-
derived laminin-2 and -4 was previously shown to consist of
300 and 80 kDa components [20]. The two bands of LG1^3
could not be separated from each other on a Superose 12
column, indicating non-covalent association. Separation was
achieved at acidic pH by reverse phase chromatography, al-
lowing the 26 kDa band to be obtained in pure form. Mass
spectroscopy of this component showed a major signal of 19.7
kDa, which was smaller than the calculated mass for the en-
tire LG3 module (22.1 kDa). Cleavage of the truncated frag-
ment LG3 by CNBr should give rise to four fragments [13]
(including I2642M, Fig. 1) with di¡erent molecular masses (in
parentheses with position numbers) : CB1 from the N-termi-
nus of unpredicted size, CB2 (4348.5 Da; 2603^2642), CB3
(5348.2 Da; 2643^2691) and the C-terminal CB4 (4801.5 Da;
2692^2735). Edman degradation of the whole digest identi¢ed
the sequences of CB2^CB4 but no additional N-terminal se-
quences. Mass spectroscopy demonstrated major signals of
4348 and 4802 Da, matching CB2 and CB4, while CB3 could
not be detected, presumably because it was glycosylated. A
third major signal of 3020 Da was seen, however, and this
matched the calculated mass of 3020.5 of a more N-terminal
sequence (2576^2602; starting with QTT), assuming the N-
terminal Q has been converted to pyroglutamic acid and con-
tains homoserine lactone at the C-terminus. This peptide CB1
had, as expected, a blocked N-terminus and started just ad-
jacent to the cluster of basic amino acid residues. The calcu-
lated mass of the truncated fragment LG3 was therefore 17.6
kDa, indicating that the 2 kDa larger mass actually found (see
above) is due to post-translational modi¢cations.
For the further characterization of tissue forms of the lam-
inin K2 chain, rabbit antisera were generated against mouse
fragments LG1^3 and LG4^5 and both showed a high ELISA
titer (1:105) for the antigen used in immunization. The cross-
reaction between the two fragments and with corresponding
K1 chain fragments of mouse laminin-1 (E3, E8) was at least
30-fold lower. However, both antisera showed a distinct cross-
reaction with human laminin-2 and -4 which contain the K2
chain. Immunoblotting of these human laminins demon-
strated staining of an 80 kDa band by the antiserum against
LG4^5. The same staining was observed with the antiserum
against LG1^3, but in addition a weaker reaction with a band
of about 250^300 kDa was seen (Fig. 4). The same 80 kDa
band could be also detected in detergent extracts of mouse
muscle (data not shown). No reaction was observed with the
laminin-1 K1 chain, underscoring the speci¢city of these anti-
bodies (Fig. 4).
4. Discussion
The successful recombinant production of four LG modules
in mammalian cells demonstrates that they represent autono-
mously folding units within the laminin K2 chain G domain.
It is likely that this is the case for most if not all of the LG
modules in the other four laminin K chains, since they are
similar in length and module borders. The accurate selection
of borders is crucial, as shown here by the need to correct the
C-terminal end of the LG5 module. Module LG3 was not
obtained in detectable amounts, which could re£ect its vulner-
ability to proteolysis, a process which may be more extensive
if the module is not protected by its non-covalent association
with other LG modules as in fragment LG1^3. All LG mod-
ules showed a globular shape by electron microscopy, indica-
tive of proper folding. In addition, they were modi¢ed mainly
FEBS 20079 9-4-98
Fig. 4. Immunoblotting of laminins with antisera raised against the
G domain of the mouse laminin K2 chain. The antisera were against
fragments LG1^3 (lanes 1, 2) and LG4^5 (lanes 3, 4). A mixture of
human placenta laminin-2 and -4 (lanes 2, 3) and of mouse laminin-
1 (lanes 1, 4) was used at 0.5 Wg/lane. Samples were reduced and
the electrophoresis was calibrated with reduced marker proteins in-
dicated in kDa in the left margin.
Fig. 3. Electron microscopy after rotary shadowing of recombinant
LG fragments. A: LG2, B: LG4, C: LG4^5 and D: LG1^3. The
magni¢cation bar (100 nm) is representative for all sections.
J.F. Talts et al./FEBS Letters 426 (1998) 71^7674
by N-glycosylation, in accordance with the presence of poten-
tial acceptor sites.
Sequencing of the parental cDNA clone pmm 16 as well as
of a partial PCR product revealed the deletion of an SMKA
sequence in the LG2 module not found before for the cDNA
sequence of human and mouse laminin K2 chain [12,13]. This
deletion corresponds exactly to the 12 bp exon 52 of the
human K2 chain gene [33], suggesting that this loss has oc-
curred by mRNA splicing. This deletion does not seem to
interfere with e⁄cient folding of the corresponding recombi-
nant fragment. Of particular interest, however, is that similar
short deletions occur in two of the LG modules of agrin and
are correlated with a loss of acetylcholine receptor clustering
activity [4,34].
Recombinant fragment LG1^3 consistently showed an al-
most complete conversion into 60 and 26 kDa fragments by
unknown proteases of the transfected mammalian cells. Mass
spectroscopy has now been used to unequivocally localize the
cleavage site to a unique sequence region RRKRRQT (posi-
tions 2571^2577) which is conserved in the human K2 chain
[12] but not found in any other laminin K chain. Cleavage of
the R^Q peptide bond is accompanied by cyclization of the Q,
which then resists Edman degradation. The preceding se-
quence is similar to the basic (B) residue sequence motif
BXBB, which represents a typical cleavage site for furin-like
proteases that are involved in the conversion of precursor
forms of various extracellular proteins [35] and is, for exam-
ple, apparently cleaved in collagen XVI in order to release a
globular domain [36]. The formation of a cyclic N-terminal Q
is also characteristic of several procollagens and occurs after
cleavage of the aminopropeptide by a speci¢c protease [37]
as a step preceding e⁄cient ¢bril formation. The proteases
involved in the conversion of the G domain of the laminin
K2 chain still remain to be identi¢ed. A similar proteolytic
cleavage has been reported for the laminin K3 chain and
may occur between modules LG3 and LG4 [38]. This indicates
that modi¢cation of the G domain exists in several laminin
isoforms even though it may not involve the same cleavage
sites.
The cleavage data obtained with the recombinant LG do-
mains predicts the existence of a fragment consisting of LG4,
LG5 and a large part of LG3 in K2 chain-containing laminins
with a minimal molecular mass of 73 kDa based on electro-
phoresis (Table 1) and mass spectroscopy. This is in good
agreement with the identi¢cation of an 80 kDa component
found in puri¢ed laminins-2 and -4 [20], which in the present
study reacted with antisera against LG4^5 and LG1^3. The
latter antiserum also reacted with a 250^300 kDa component
which should consist of the remaining part of the K2 chain
including the LG1 and LG2 modules. Comparable results
were reported for antibodies raised against the C-terminal
part of the G domain of the K2 chain and synthetic peptides
derived from the LG2 module [24]. Together, the data indicate
that the cleavage identi¢ed here for LG1^3 also occurs in
tissue-derived laminins. This cleavage, however, does not
cause the dissociation of the 80 kDa component from laminin
[20]. Whether this has functional consequences remains to be
studied in further recombinant experiments.
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